RE: Video28 Nov 2019 20:54
last year I went through Chemo - a purine analogue that reduced me to a shell of myself/ Unfortunately the outcome was not a total success and I was said to have minimal residual disease. This year I was given a therapeutic drug to try to capture the MRD - Only finished 4 weeks ago so still awaiting results on the outcome.
Research carried out since last year has shown that a concurrent dosage of both the purine analogue and the therapy resulted in 100% remission with less toxicity. My expectation is that next year this combination therapy will be the track that the consultant will take. The ability to combine both drugs in some format rather than two individual drugs concurrently, will improve efficacy and reduce toxicity.
The combination therapy that Nuformix is aiming to achieve will be significant and transformational. Whilst not been related specifically to my cancer at this point, the outcomes they are targeting could benefit oncology patients globally.
GLA